Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function

ClinicalTrials.gov ID: NCT00401687

Public ClinicalTrials.gov record NCT00401687. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Phase IV Study to Evaluate the Ability of Definity® Enhanced Versus Unenhanced Echocardiography to Improve the Accuracy and Reproducibility of Left Ventricular Ejection Fraction When Compared to Cardiac Magnetic Resonance Imaging

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical research study is to demonstrate the ability of Definity® enhanced versus unenhanced cardiac ultrasound to improve the accuracy and reproducibility of left ventricular ejection fraction (EF) when compared to magnetic resonance imaging (MRI).

Study identification

NCT ID
NCT00401687
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Lantheus Medical Imaging
Industry
Enrollment
131 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2006 (Type not available)
Primary completion
Jun 2007 (Actual)
Completion
Apr 2008 (Actual)
Last update posted
May 20, 2011

2006 – 2008

United States locations

U.S. sites
10
U.S. states
10
U.S. cities
10
Facility City State ZIP Site status
University of Arizona Tucson Arizona 85727 —
University of Chicago Medical Center Chicago Illinois 60637 —
Washington Hospital Center Washington DC Maryland 20010 —
Saint Lukes Mid America Heart Institute Kansas City Missouri 64111 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
Duke University Medical Center Durham North Carolina 27710 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Oregon Health & Science University Portland Oregon 97239 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
University of Texas Medical Branch Galveston Texas 77555 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00401687, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 20, 2011 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00401687 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →